{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:25:41Z","timestamp":1788175541982,"version":"build-2803163510"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T00:00:00Z","timestamp":1730678400000},"content-version":"am","delay-in-days":339,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 #HL155718-01"],"award-info":[{"award-number":["R01 #HL155718-01"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.bcp.2023.115904","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T19:13:54Z","timestamp":1699038834000},"page":"115904","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["RGS proteins and cardiovascular Angiotensin II Signaling: Novel opportunities for therapeutic targeting"],"prefix":"10.1016","volume":"218","author":[{"given":"Anastasios","family":"Lymperopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordana I.","family":"Borges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee A.","family":"Stoicovy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2023.115904_b0005","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/bs.ircmb.2018.02.007","article-title":"Biased Agonism\/Antagonism of Cardiovascular GPCRs for Heart Failure Therapy","volume":"339","author":"Desimine","year":"2018","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"10.1016\/j.bcp.2023.115904_b0010","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ejphar.2015.05.019","article-title":"GPCR signaling and cardiac function","volume":"763","author":"Capote","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2023.115904_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2021.109967","article-title":"Adrenal angiotensin II type 1 receptor biased signaling: The case for \u201cbiased\u201d inverse agonism for effective aldosterone suppression","volume":"82","author":"Ferraino","year":"2021","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bcp.2023.115904_b0020","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1161\/CIRCRESAHA.118.311403","article-title":"G-Protein-Coupled Receptors in Heart Disease","volume":"123","author":"Wang","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2023.115904_b0025","first-page":"415","article-title":"International union of pharmacology. XXIII. The angiotensin II receptors","volume":"52","author":"de Gasparo","year":"2000","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bcp.2023.115904_b0030","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1124\/pharmrev.120.000281","article-title":"The Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic Target","volume":"74","author":"Steckelings","year":"2022","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bcp.2023.115904_b0035","doi-asserted-by":"crossref","first-page":"492","DOI":"10.2174\/1381612826666200115092015","article-title":"Emerging Role of Angiotensin AT2 Receptor in Anti-Inflammation: An Update","volume":"26","author":"Patel","year":"2020","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bcp.2023.115904_b0040","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3389\/fendo.2019.00519","article-title":"The Role of \u03b2-Arrestin Proteins in Organization of Signaling and Regulation of the AT1 Angiotensin Receptor","volume":"10","author":"Turu","year":"2019","journal-title":"Front Endocrinol (lausanne)."},{"key":"10.1016\/j.bcp.2023.115904_b0045","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.beem.2018.02.003","article-title":"Novel mechanisms of G-protein-coupled receptors functions: AT1 angiotensin receptor acts as a signaling hub and focal point of receptor cross-talk","volume":"32","author":"T\u00f3th","year":"2018","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2023.115904_b0050","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.3390\/cells11213336","article-title":"Angiotensin II-Induced Signal Transduction Mechanisms for Cardiac Hypertrophy","volume":"11","author":"Bhullar","year":"2022","journal-title":"Cells."},{"key":"10.1016\/j.bcp.2023.115904_b0055","doi-asserted-by":"crossref","DOI":"10.1177\/1753944719868134","article-title":"The place of ARBs in heart failure therapy: is aldosterone suppression the key?","volume":"13","author":"Markan","year":"2019","journal-title":"Ther. Adv. Cardiovasc. Dis."},{"key":"10.1016\/j.bcp.2023.115904_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115238","article-title":"Novel AT2R agonist, \u03b2-Pro7Ang III, is cardio- and vaso-protective in diabetic spontaneously hypertensive rats","volume":"165","author":"Li","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2023.115904_b0065","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.3390\/cells12101373","article-title":"Cardiovascular Protective Effects of NP-6A4, a Drug with the FDA Designation for Pediatric Cardiomyopathy, in Female Rats with Obesity and Pre-Diabetes","volume":"12","author":"Belenchia","year":"2023","journal-title":"Cells."},{"key":"10.1016\/j.bcp.2023.115904_b0070","first-page":"1","article-title":"Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling","volume":"53","author":"Ferguson","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bcp.2023.115904_b0075","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/bip.22836","article-title":"Invited review: Activation of G proteins by GTP and the mechanism of G\u03b1-catalyzed GTP hydrolysis","volume":"105","author":"Sprang","year":"2016","journal-title":"Biopolymers"},{"key":"10.1016\/j.bcp.2023.115904_b0080","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/bs.pmbts.2022.06.006","article-title":"Cardiovascular GPCR regulation by regulator of G protein signaling proteins","volume":"193","author":"Lymperopoulos","year":"2022","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.bcp.2023.115904_b0085","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1161\/01.RES.0000158287.49872.4e","article-title":"Multi-tasking RGS proteins in the heart: the next therapeutic target?","volume":"96","author":"Riddle","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2023.115904_b0090","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1161\/CIRCRESAHA.110.231423","article-title":"Regulators of G-protein signaling in the heart and their potential as therapeutic targets","volume":"109","author":"Zhang","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2023.115904_b0095","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1152\/physiolgenomics.00037.2018","article-title":"Regulators of G protein signaling in cardiovascular function during pregnancy","volume":"50","author":"Perschbacher","year":"2018","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.bcp.2023.115904_b0100","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1124\/pr.117.015354","article-title":"Genetic Analysis of Rare Human Variants of Regulators of G Protein Signaling Proteins and Their Role in Human Physiology and Disease","volume":"70","author":"Squires","year":"2018","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bcp.2023.115904_b0105","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.pharmthera.2007.09.005","article-title":"R4 RGS proteins: regulation of G-protein signaling and beyond","volume":"116","author":"Bansal","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2023.115904_b0110","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.cell.2020.08.052","article-title":"A Global Map of G Protein Signaling Regulation by RGS Proteins","volume":"183","author":"Masuho","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2023.115904_b0115","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1042\/bj20021769","article-title":"The aorta and heart differentially express RGS (regulators of G-protein signalling) proteins that selectively regulate sphingosine 1-phosphate, angiotensin II and endothelin-1 signalling","volume":"371","author":"Cho","year":"2003","journal-title":"Biochem. J"},{"key":"10.1016\/j.bcp.2023.115904_b0120","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1210\/endo.138.2.5034","article-title":"Potential role for a regulator of G protein signaling (RGS3) in gonadotropin-releasing hormone (GnRH) stimulated desensitization","volume":"138","author":"Neill","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2023.115904_b0125","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1161\/CIRCRESAHA.113.300308","article-title":"Adrenergic nervous system in heart failure: pathophysiology and therapy","volume":"113","author":"Lymperopoulos","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2023.115904_b0130","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1134\/S000629791613006X","article-title":"Myosin Light Chain Kinase MYLK1: Anatomy, Interactions, Functions, and Regulation","volume":"81","author":"Khapchaev","year":"2016","journal-title":"Biochemistry (Mosc.)"},{"key":"10.1016\/j.bcp.2023.115904_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2021.110134","article-title":"Calcineurin in the heart: New horizons for an old friend","volume":"87","author":"Chaklader","year":"2021","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bcp.2023.115904_b0140","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1146\/annurev-pharmtox-051421-111814","article-title":"CaMKII as a Therapeutic Target in Cardiovascular Disease","volume":"63","author":"Reyes Gaido","year":"2023","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.bcp.2023.115904_b0145","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/01.CIR.99.3.441","article-title":"RGS4 inhibits G-protein signaling in cardiomyocytes","volume":"99","author":"Tamirisa","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2023.115904_b0150","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00395-010-0098-z","article-title":"Novel insights into the mechanisms mediating the local antihypertrophic effects of cardiac atrial natriuretic peptide: role of cGMP-dependent protein kinase and RGS2","volume":"105","author":"Klaiber","year":"2010","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.bcp.2023.115904_b0155","first-page":"H147","article-title":"Regulator of G protein signaling 2 is a functionally important negative regulator of angiotensin II-induced cardiac fibroblast responses","volume":"301","author":"Zhang","year":"2011","journal-title":"Am. J. Phys. Heart Circ. Phys."},{"key":"10.1016\/j.bcp.2023.115904_b0160","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/jcb.24741","article-title":"Regulator of G protein signaling 3 protects against cardiac hypertrophy in mice","volume":"115","author":"Liu","year":"2014","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bcp.2023.115904_b0165","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1161\/HYPERTENSIONAHA.115.05957","article-title":"Regulator of G-Protein Signaling 10 Negatively Regulates Cardiac Remodeling by Blocking Mitogen-Activated Protein Kinase-Extracellular Signal-Regulated Protein Kinase 1\/2 Signaling","volume":"67","author":"Miao","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2023.115904_b0170","doi-asserted-by":"crossref","first-page":"e009179","DOI":"10.1161\/JAHA.118.009179","article-title":"Regulator of G Protein Signaling 6 Facilities Cardiac Hypertrophy by Activating Apoptosis Signal-Regulating Kinase 1\u2013P38\/c-JUN N-Terminal Kinase 1\/2 Signaling","volume":"7","author":"Huang","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.bcp.2023.115904_b0175","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1161\/HYPERTENSIONAHA.115.06877","article-title":"Pivotal Role of Regulator of G-protein Signaling 12 in Pathological Cardiac Hypertrophy","volume":"67","author":"Huang","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2023.115904_b0180","article-title":"Angiotensin II and vascular injury","author":"Montezano","year":"201416431","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.bcp.2023.115904_b0185","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1042\/CS20060342","article-title":"Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology","volume":"112","author":"Higuchi","year":"2007","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.bcp.2023.115904_b0190","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41392-023-01430-7","article-title":"Signaling pathways in vascular function and hypertension: molecular mechanisms and therapeutic interventions","volume":"8","author":"Ma","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bcp.2023.115904_b0195","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bcp.2018.02.012","article-title":"Evolving mechanisms of vascular smooth muscle contraction highlight key targets in vascular disease","volume":"153","author":"Liu","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2023.115904_b0200","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1124\/mol.57.3.460","article-title":"Specific regulation of RGS2 messenger RNA by angiotensin II in cultured vascular smooth muscle cells","volume":"57","author":"Grant","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2023.115904_b0205","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1113\/expphysiol.2007.038240","article-title":"Regulator of G protein signalling 2 ameliorates angiotensin II-induced hypertension in mice","volume":"92","author":"Hercule","year":"2007","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.bcp.2023.115904_b0210","doi-asserted-by":"crossref","first-page":"25278","DOI":"10.1074\/jbc.M611206200","article-title":"Group VIA phospholipase A2 (iPLA2beta) participates in angiotensin II-induced transcriptional up-regulation of regulator of g-protein signaling-2 in vascular smooth muscle cells","volume":"282","author":"Xie","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2023.115904_b0215","doi-asserted-by":"crossref","first-page":"44646","DOI":"10.1074\/jbc.M111.265462","article-title":"Identification of a cAMP-response element in the regulator of G-protein signaling-2 (RGS2) promoter as a key cis-regulatory element for RGS2 transcriptional regulation by angiotensin II in cultured vascular smooth muscles","volume":"286","author":"Xie","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2023.115904_b0220","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/hr.2015.154","article-title":"The angiotensin II receptor antagonist, losartan, enhances regulator of G protein signaling 2 mRNA expression in vascular smooth muscle cells of Wistar rats","volume":"39","author":"Wu","year":"2016","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.bcp.2023.115904_b0225","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/hr.2010.184","article-title":"Impact of RGS2 deficiency on the therapeutic effect of telmisartan in angiotensin II-induced aortic aneurysm","volume":"33","author":"Matsumoto","year":"2010","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.bcp.2023.115904_b0230","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.vph.2018.04.002","article-title":"Vascular wall regulator of G-protein signalling-1 (RGS-1) is required for angiotensin II-mediated blood pressure control","volume":"108","author":"Patel","year":"2018","journal-title":"Vasc.Pharmacol."},{"key":"10.1016\/j.bcp.2023.115904_b0235","doi-asserted-by":"crossref","first-page":"34531","DOI":"10.1074\/jbc.274.49.34531","article-title":"Feedback inhibition of G protein-coupled receptor kinase 2 (GRK2) activity by extracellular signal-regulated kinases","volume":"274","author":"Pitcher","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2023.115904_b0240","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1124\/mol.118.112524","article-title":"Small-Molecule G Protein-Coupled Receptor Kinase Inhibitors Attenuate G Protein-Coupled Receptor Kinase 2-Mediated Desensitization of Vasoconstrictor-Induced Arterial Contractions","volume":"94","author":"Rainbow","year":"2018","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2023.115904_b0245","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1091\/mbc.e04-06-0479","article-title":"Identification and characterization of regulator of G protein signaling 4 (RGS4) as a novel inhibitor of tubulogenesis: RGS4 inhibits mitogen-activated protein kinases and vascular endothelial growth factor signaling","volume":"16","author":"Albig","year":"2005","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.bcp.2023.115904_b0250","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/ki.2014.364","article-title":"RGS4 inhibits angiotensin II signaling and macrophage localization during renal reperfusion injury independent of vasospasm","volume":"87","author":"Pang","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.bcp.2023.115904_b0255","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1161\/HYPERTENSIONAHA.117.09757","article-title":"Angiotensin II Type 1 Receptor Mechanoactivation Involves RGS5 (Regulator of G Protein Signaling 5) in Skeletal Muscle Arteries: Impaired Trafficking of RGS5 in Hypertension","volume":"70","author":"Hong","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2023.115904_b0260","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.yjmcc.2007.11.019","article-title":"RGS5, RGS4, and RGS2 expression and aortic contractibility are dynamically co-regulated during aortic banding-induced hypertrophy","volume":"44","author":"Wang","year":"2008","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bcp.2023.115904_b0265","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1161\/CIRCRESAHA.112.271577","article-title":"PPAR\u03b3 regulates resistance vessel tone through a mechanism involving RGS5-mediated control of protein kinase C and BKCa channel activity","volume":"111","author":"Ketsawatsomkron","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2023.115904_b0270","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1124\/jpet.116.233106","article-title":"Vascular and Central Activation of Peroxisome Proliferator-Activated Receptor-\u03b2 Attenuates Angiotensin II-Induced Hypertension: Role of RGS-5","volume":"358","author":"Romero","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2023.115904_b0275","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1161\/CIRCRESAHA.111.300142","article-title":"Regulator of G-protein signaling 5 controls blood pressure homeostasis and vessel wall remodeling","volume":"112","author":"Holobotovskyy","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2023.115904_b0280","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/FJC.0000000000001213","article-title":"Adrenal G Protein-Coupled Receptors and the Failing Heart: A Long-distance","volume":"80","author":"Borges","year":"2022","journal-title":"Yet Intimate Affair. J Cardiovasc Pharmacol."},{"key":"10.1016\/j.bcp.2023.115904_b0285","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s10571-010-9596-7","article-title":"Inhibition of Ca2+ channels and adrenal catecholamine release by G protein coupled receptors","volume":"30","author":"Currie","year":"2010","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.bcp.2023.115904_b0290","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.3390\/cells10061552","article-title":"Impact of Aldosterone on the Failing Myocardium: Insights from Mitochondria and Adrenergic Receptors Signaling and Function","volume":"10","author":"Guitart-Mampel","year":"2021","journal-title":"Cells."},{"key":"10.1016\/j.bcp.2023.115904_b0295","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.biocel.2016.02.003","article-title":"GPCRs of adrenal chromaffin cells & catecholamines: The plot thickens","volume":"77","author":"Lymperopoulos","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bcp.2023.115904_b0300","doi-asserted-by":"crossref","first-page":"14335","DOI":"10.1038\/ncomms14335","article-title":"Arrestin-biased GPCR agonism induces acute catecholamine secretion through TRPC3 coupling","volume":"8","author":"Liu","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2023.115904_b0305","doi-asserted-by":"crossref","first-page":"5706","DOI":"10.1210\/en.2008-0717","article-title":"Regulator of G protein signaling-4 controls fatty acid and glucose homeostasis","volume":"149","author":"Iankova","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2023.115904_b0310","first-page":"417","article-title":"Role of calcium and other mediators in aldosterone secretion from the adrenal glomerulosa cells","volume":"46","author":"Ganguly","year":"1994","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bcp.2023.115904_b0315","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.mce.2003.12.020","article-title":"Adrenocortical cell lines","volume":"228","author":"Rainey","year":"2004","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bcp.2023.115904_b0320","doi-asserted-by":"crossref","first-page":"5825","DOI":"10.1073\/pnas.0811706106","article-title":"An adrenal beta-arrestin 1-mediated signaling pathway underlies angiotensin II-induced aldosterone production in vitro and in vivo","volume":"106","author":"Lymperopoulos","year":"2009","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2023.115904_b0325","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jacc.2010.08.635","article-title":"Adrenal beta-arrestin 1 inhibition in vivo attenuates post-myocardial infarction progression to heart failure and adverse remodeling via reduction of circulating aldosterone levels","volume":"57","author":"Lymperopoulos","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bcp.2023.115904_b0330","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/bs.mie.2023.01.001","article-title":"Molecular regulation of PLC\u03b2 signaling","volume":"682","author":"Ubeysinghe","year":"2023","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bcp.2023.115904_b0335","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3390\/ijms21020574","article-title":"GRK2-Mediated Crosstalk Between \u03b2-Adrenergic and Angiotensin II Receptors Enhances Adrenocortical Aldosterone Production In Vitro and In Vivo","volume":"21","author":"Pollard","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2023.115904_b0340","doi-asserted-by":"crossref","first-page":"8116","DOI":"10.1038\/srep08116","article-title":"Suppression of adrenal \u03b2arrestin1-dependent aldosterone production by ARBs: head-to-head comparison","volume":"5","author":"Dabul","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2023.115904_b0345","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1677\/JOE-07-0153","article-title":"Regulators of G-protein signaling 4 in adrenal gland: localization, regulation, and role in aldosterone secretion","volume":"194","author":"Romero","year":"2007","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bcp.2023.115904_b0350","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1210\/en.2005-1532","article-title":"RGS2 is regulated by angiotensin II and functions as a negative feedback of aldosterone production in H295R human adrenocortical cells","volume":"147","author":"Romero","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2023.115904_b0355","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nm1553","article-title":"Adrenal GRK2 upregulation mediates sympathetic overdrive in heart failure","volume":"13","author":"Lymperopoulos","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2023.115904_b0360","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJMra000050","article-title":"Aldosterone in congestive heart failure","volume":"345","author":"Weber","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2023.115904_b0365","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1016\/j.jacc.2014.09.070","article-title":"Different potencies of angiotensin receptor blockers at suppressing adrenal \u03b2-Arrestin1-dependent post-myocardial infarction hyperaldosteronism","volume":"64","author":"Lymperopoulos","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bcp.2023.115904_b0370","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1210\/me.2015-1305","article-title":"GRK2 Up-Regulation Creates a Positive Feedback Loop for Catecholamine Production in Chromaffin Cells","volume":"30","author":"Jafferjee","year":"2016","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bcp.2023.115904_b0375","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1124\/jpet.115.231571","article-title":"Digoxin-Mediated Upregulation of RGS2 Protein Protects against Cardiac Injury","volume":"357","author":"Sj\u00f6gren","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2023.115904_b0380","doi-asserted-by":"crossref","first-page":"6344","DOI":"10.1038\/srep06344","article-title":"A neurostimulant para-chloroamphetamine inhibits the arginylation branch of the N-end rule pathway","volume":"4","author":"Jiang","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2023.115904_b0385","doi-asserted-by":"crossref","first-page":"18571","DOI":"10.1074\/jbc.REV119.007060","article-title":"Regulator of G-protein signaling (RGS) proteins as drug targets: Progress and future potentials","volume":"294","author":"O'Brien","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2023.115904_b0390","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1124\/mol.106.028670","article-title":"Identification of small-molecule inhibitors of RGS4 using a high-throughput flow cytometry protein interaction assay","volume":"71","author":"Roman","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2023.115904_b0395","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1124\/mol.119.117176","article-title":"An Interhelical Salt Bridge Controls Flexibility and Inhibitor Potency for Regulators of G-protein Signaling Proteins 4, 8, and 19","volume":"96","author":"Shaw","year":"2019","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2023.115904_b0400","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2210-9-9","article-title":"A covalent peptide inhibitor of RGS4 identified in a focused one-bead, one compound library screen","volume":"9","author":"Roof","year":"2009","journal-title":"BMC Pharmacol."},{"key":"10.1016\/j.bcp.2023.115904_b0405","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1124\/mol.110.065128","article-title":"Reversible, allosteric small-molecule inhibitors of regulator of G protein signaling proteins","volume":"78","author":"Blazer","year":"2010","journal-title":"Mol. Pharmacol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295223004975?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295223004975?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T01:08:34Z","timestamp":1731028114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295223004975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":81,"alternative-id":["S0006295223004975"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115904","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RGS proteins and cardiovascular Angiotensin II Signaling: Novel opportunities for therapeutic targeting","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115904","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115904"}}